Hospital-acquired pneumonia: Overview of the current state of the art for prevention and control

  • R. P. Wenzel
Current Topic: Review

Abstract

Hospital-acquired pneumonia affects at least 250,000 patients in U.S. acute care institutions each year and is associated with a crude mortality of approximately 30 %. Cases occur at a rate of 0.5–1 per 100 admissions, constituting 10–15 % of all nosocomial infections and directly accounting for approximately one-third (10 %) of the total mortality. It is likely, therefore, that nosocomial pneumonia represents an important cause of death. No recent large-scale study has systematically examined the true bacterial etiology of hospital-acquired pneumonia utilizing reliable techniques that bypass the oral flora. In the absence of such data, the current approach to therapy based on the examination of sputum is not optimal. Studies that focus on pathogenesis point to the stomach as an important reservoir of infecting organisms. Recent studies suggest that rates of pneumonia can be reduced either by selective decontamination of the digestive tract with antibiotic prophylaxis or by utilizing stress ulcer prophylaxis, which maintains normally low gastric pH. It seems that the time is propitious to examine prehospital determinants of nosocomial infection, with the goal of further preventing these life-threatening events in the hospital.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Graybill, J. R., Marshall, L. W., Charache, P., Wallace, C. R., Melvin, V. B. Nosocomial pneumonia. A continuing major problem. American Review of Respiratory Disease 1973, 108: 1130–1140.PubMedGoogle Scholar
  2. 2.
    Gross, P. A., Neu, H. C., Aswapokee, P., Van Antwerper, C., Aswapokee, N. Deaths from nosocomial infection: experience in a university hospital and a community hospital. American Journal of Medicine 1980, 68: 219–223.CrossRefPubMedGoogle Scholar
  3. 3.
    Veazey, J. M. Hospital-acquired pneumonia. In: Wenzel, R. P. (ed.): CRC handbook of hospital-acquired infections. CRC Press, Boca Raton, FL, 1981, p. 341–369.Google Scholar
  4. 4.
    Haley, R. W., Culver, D. H., White, J. W., Morgan, W. M., Emori, T. G. The SENIC part 1 of 4 parts. The nationwide nosocomial infection rate: a new need for vital statistics. American Journal of Epidemiology 1985, 121: 159–167.PubMedGoogle Scholar
  5. 5.
    Pennington, J. E. Hospital-acquired pneumonia. In: Wenzel, R. P. (ed.): Prevention and control of nosocomial infections. Williams & Wilkins, Baltimore, MD, 1987, p. 321–334.Google Scholar
  6. 6.
    Celis, R., Torres, A., Gatell, J. M., Almela, M., Rodriguez-Roisin, R., Agusti-Vidal, A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988, 93: 318–324.PubMedGoogle Scholar
  7. 7.
    Wenzel, R. P. The mortality of hospital-acquired blood-stream infections: need for a new vital statistic? International Journal of Epidemiology 1988, 17: 225–227.PubMedGoogle Scholar
  8. 8.
    National Center for Health Statistics 1986, Vital Statistics Data. Washington, DC, 35 (6): Supplement 2 (Sept. 26, 1986).Google Scholar
  9. 9.
    Freeman, J., Rosner, B. A., McGowan, J. E. Adverse effects of nosocomial infections. Journal of Infectious Diseases 1979, 140: 732–740.PubMedGoogle Scholar
  10. 10.
    Wimberly, N. W., Bass, J. B., Boyd, B. W., Kirkpatrick, M. B., Serio, R., Pollock, H. M. Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infection. Chest 1982, 81: 556–562.PubMedGoogle Scholar
  11. 11.
    Pollock, H. M., Hawkins, E. L., Bonner, J. R., Sparkman, T., Bass, J. B. Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy. Journal of Clinical Microbiology 1983, 17: 255–259.PubMedGoogle Scholar
  12. 12.
    Chastre, J., Viau, F., Brun, P., Pierre, J., Dauge, M. C., Bouchama, A., Akesbi, A., Gibert, C. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. American Review of Respiratory Disease 1984, 130: 924–929.PubMedGoogle Scholar
  13. 13.
    Villers, D., Dirriennic, M., Raffi, F., Germaud, P., Baron, D., Nicolas, F., Courtieu, A. L. Reliability of the bronchoscopic protected catheter brush in intubated and ventilated patients. Chest 1985, 88: 527–530.PubMedGoogle Scholar
  14. 14.
    Torzillo, P. J., McWilliam, D. B., Young, H., Woog, R. H., Benn, R. Use of protected telescoping brush system in the management of bacterial pulmonary infection in intubated patients. British Journal of Diseases of the Chest 1985, 79: 125–131.PubMedGoogle Scholar
  15. 15.
    Baigelman, W., Bellin, S., Cupples, L. A., Berenberg, M. T. Bacteriologic assessment of the lower respiratory tract in intubated patients. Critical Care Medicine 1986, 14: 864–868.PubMedGoogle Scholar
  16. 16.
    Bartlett, J. G., O'Keefe, P., Tally, F. P., Louie, J. J., Gorbach, S. L. Bacteriology of hospital-acquired pneumonia. Archives of Internal Medicine 1986, 146: 868–871.CrossRefPubMedGoogle Scholar
  17. 17.
    Meyer, R. D. Legionella infections: a review of five years of research. Reviews of Infectious Diseases 1983, 5: 258–278.PubMedGoogle Scholar
  18. 18.
    Cohen, M., Broome, C. V. Fatal nosocomial Legionnaire's disease: clinical and epidemiological characteristics. Annals of Internal Medicine 1979, 90: 611–613.PubMedGoogle Scholar
  19. 19.
    Lehtomaki, K., Kleemola, M., Tukianen, P., Kantanen, M. L., Laitinen, L. A. Isolation ofMycoplasma pneumoniae from bronchoalveolar lavage fluid. Journal of Infectious Diseases 1987, 155: 1339–1341.PubMedGoogle Scholar
  20. 20.
    Salata, R. A., Lederman, M. M., Shlaes, D. M., Jacobs, M. R., Eckstein, E., Twerday, D., Toosi, Z., Chmielewski, R., Marino, J., King, C. H., Graham, R. C., Ellner, J. J. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. American Review of Respiratory Disease 1987, 135: 426–432.PubMedGoogle Scholar
  21. 21.
    Wenzel, F. P., Osterman, C. A., Donowitz, L. G., Hoyt, J. W., Sande, M. A., Martone, W. J., Peacock, J. E., Levine, J. I., Miller, G. B. Identification of procedure-related nosocomial infections in high-risk patients. Reviews of Infectious Diseases 1981, 3: 701–707.PubMedGoogle Scholar
  22. 22.
    Garibaldi, R. A., Britt, M. R., Coleman, M. L., Reading, J. C., Pace, N. L. Risk factors for postoperative pneumonia. American Journal of Medicine 1981, 70: 677–680.CrossRefPubMedGoogle Scholar
  23. 23.
    Stamm, W. E., Martin, S. M., Bennett, J. V. Epidemiology of nosocomial infections due to gram-negative bacilli: aspects relevant to development and use of vaccines. Journal of Infectious Diseases 1977, 136: Supplement: 151–160.Google Scholar
  24. 24.
    Craven, D. E., Goularte, T. A., Make, B. J. Contaminated condensate in mechanical ventilator circuits. American Review of Respiratory Disease 1984, 129: 625–628.PubMedGoogle Scholar
  25. 25.
    Daschner, F. Stress ulcer prophylaxis and the risk of nosocomial pneumonia in artifically ventilated patients. European Journal of Clinical Microbiology 1987, 6: 129–131.PubMedGoogle Scholar
  26. 26.
    Craven, D. E., Kunches, L. M., Kilinsky, V., Lichtenburg, D. A., Make, B. J., McCabe, W. R. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. American Review of Respiratory Disease 1986, 133: 792–796.PubMedGoogle Scholar
  27. 27.
    Hillman, K. M., Riordan, T., O'Farrell, S. M., Tobaqchali, S. Colonization of the gastric contents in critically ill patients. Critical Care Medicine 1982, 10: 444–447.PubMedGoogle Scholar
  28. 28.
    Mauritz, W., Graninger, W., Schindler, I., Kamer, J., Zadrobilek, E., Sporn, P. Bacterial flora in gastric juice and bronchial secretion in intensive care patients under long-term respirator treatment. Anaesthesist 1985, 34: 203–207.PubMedGoogle Scholar
  29. 29.
    Donowitz, L. G., Page, C., Mileur, B. L., Guenthner, S. H. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infection Control 1986, 7: 23–26.PubMedGoogle Scholar
  30. 30.
    Daschner, F., Reuschenbach, K., Pfisterer, J., Kappstein, I., Vogel, W., Krieg, N., Just, H. The influence of stress ulcer prophylaxis on the incidence of pneumonia in artifically ventilated patients. Anaesthesist 1987, 36: 9–18.PubMedGoogle Scholar
  31. 31.
    Stoutenbeek, C. P., Hendrik, K. F., VanSaene, M. D., Miranda, D. R., Zandstra, D. F., Langrehr, D. The effect of oropharyngeal decontamination using topical non-absorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. Journal of Trauma 1987, 27: 357–364.PubMedGoogle Scholar
  32. 32.
    Atherton, S. T., White, D. J. Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet 1978, ii: 968–969.CrossRefGoogle Scholar
  33. 33.
    Kappstein, I., Engels, I. Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid. European Journal of Clinical Microbiology 1987, 6: 216–217.Google Scholar
  34. 34.
    Driks, M. R., Craven, D. E., Celli, B. R., Manning, M., Burke, R., Garvin, G. M., Kunches, L. M., Farber, H. W., Wedel, S. A., McCabe, W. R. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization. New England Journal of Medicine 1987, 317: 1376–1382.PubMedGoogle Scholar
  35. 35.
    McA-Ledingham, I., Eastaway, A. T., McKay, I. C., Alcock, S. R., McDonald, J. C., Ramsay, G. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1988, i: 785–790.CrossRefGoogle Scholar
  36. 36.
    Pierce, A. K., Sanford, J. P. Aerobic gram-negative bacillary pneumonias. American Review of Respiratory Disease 1974, 110: 647–658.PubMedGoogle Scholar
  37. 37.
    Woods, D. E., Straus, D. C., Johanson, W. G., Berry, V. K., Bass, J. A. Role of pili in adherence ofPseudomonas aeruginosa to mammalian buccal epithelial cells. Infection and Immunity 1980, 29: 1146–1151.PubMedGoogle Scholar
  38. 38.
    Woods, D. E., Straus, D. C., Johanson, W. G., Bass, J. A. Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vitro. Journal of Clinical Investigation 1981, 68: 1435–1440.PubMedGoogle Scholar
  39. 39.
    Ramphal, R., Pyle, M. Evidence for mucins and sialic acid as receptors forPseudomonas aeruginosa in the lower respiratory tract. Infection and Immunity 1983, 41: 339–344.PubMedGoogle Scholar
  40. 40.
    Woods, D. E., Straus, D. C., Johanson, W. G., Bass, J. A. Role of fibronectin in the prevention of adherence ofPseudomonas aeruginosa to buccal cells. Journal of Infectious Diseases 1981, 143: 784–790.PubMedGoogle Scholar
  41. 41.
    Abraham, S. N., Beachey, E. H., Simpson, W. A. Adherence ofStreptococcus pyogenes, Escherichia coli, andPseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infection and Immunity 1983, 41: 1261–1268.PubMedGoogle Scholar
  42. 42.
    Proctor, R. A. Fibronectin: a brief overview of its structure, function, and physiology. Reviews of Infectious Diseases 1987, 9, Supplement: 317–321.Google Scholar
  43. 43.
    Proctor, R. A. The staphylococcal fibronectin receptor: evidence for its importance in invasive infections. Reviews of Infectious Diseases 1987, 9, Supplement: 335–340.Google Scholar
  44. 44.
    Proctor, R. A., Olbrante, P. J., Mosher, D. F. Subinhibitory concentrations of antibiotics alter fibronectin binding toStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1983, 24: 823–826.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1989

Authors and Affiliations

  • R. P. Wenzel
    • 1
  1. 1.Division of Clinical Epidemiology, Department of Internal MedicineUniversity of Iowa College of Medicine, University of Iowa Hospitals and ClinicsIowa CityUSA

Personalised recommendations